Farmacijos investicijos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 8,806 | 15,700 | 10,000 | 940,400 | 12,500 | 24,000 | 19,000 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 2,324 | 2,379 | 2,699 | -3,979 | 29,116 | -7,448 | 1,805 | -5,000 |
| Equity | 36,794 | 39,173 | 41,872 | 37,893 | 67,010 | 59,561 | 61,366 | 56,366 |
| Liabilities | 741,371 | 777,091 | 757,543 | 854,276 | 437 | 1,203 | 2,480 | 2,597 |
| Non-current assets | 774,872 | 810,372 | 790,202 | 887,674 | 240 | 240 | 240 | 240 |
| Current assets | 403 | 10 | 8,536 | 717 | 67,079 | 60,396 | 62,678 | 58,723 |
| Total assets | 775,275 | 810,382 | 798,738 | 888,391 | 67,319 | 60,636 | 62,918 | 58,963 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,337 | 4,208 | 4,761 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +78.3% | -36.3% | +9304.0% | -98.7% | +92.0% | -20.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.3% | 0.3% | 0.3% | -0.4% | 43.3% | -12.3% | 2.9% | -8.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.3% | 6.1% | 6.4% | -10.5% | 43.5% | -12.5% | 2.9% | -8.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 27.0% | 17.2% | -39.8% | 3.1% | -59.6% | 7.5% | -26.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 20.1 | 19.8 | 18.1 | 22.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 4,403 | 5,233 | 3,333 | 313,467 | 4,167 | 8,000 | 6,333 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Farmacijos investicijos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-16 | 2026-09-17 | 1266.47 |
| 2026-08-23 | 2026-08-25 | 196.49 |
| 2026-08-18 | 2026-08-19 | 196.49 |
| 2024-07-16 | 2024-07-16 | 385.40 |
| 2024-01-16 | 2024-01-16 | 197.43 |
| 2023-10-17 | 2023-10-18 | 2.14 |
| 2023-09-18 | 2023-09-21 | 160.53 |
| 2023-07-28 | 2023-08-07 | 21.31 |
| 2023-07-26 | 2023-07-27 | 20.61 |
| 2023-07-24 | 2023-07-25 | 21.33 |
| 2023-07-18 | 2023-07-23 | 20.61 |
| 2023-05-17 | 2023-06-12 | 70.91 |
| 2023-05-16 | 2023-05-16 | 200.91 |
| 2023-04-18 | 2023-04-19 | 31.73 |
| 2023-02-17 | 2023-03-08 | 17.22 |
| 2022-12-16 | 2022-12-20 | 94.57 |
| 2022-11-17 | 2022-11-18 | 247.87 |
| 2022-10-28 | 2022-11-16 | 3.26 |
| 2022-10-18 | 2022-10-27 | 2.61 |
| 2022-09-23 | 2022-09-25 | 5.74 |
| 2022-09-16 | 2022-09-22 | 237.74 |
| 2022-05-17 | 2022-05-19 | 224.03 |
| 2022-03-16 | 2022-03-16 | 190.95 |
| 2022-02-17 | 2022-02-21 | 243.35 |
Farmacijos investicijos - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-04 | 2026-09-19 | 0.29 |
| 2026-08-13 | 2026-08-13 | 347.95 |
| 2026-08-12 | 2026-08-12 | 345.43 |
| 2026-02-18 | 2026-03-08 | 0.64 |
| 2026-01-16 | 2026-02-16 | 0.04 |
| 2026-01-13 | 2026-01-14 | 173.67 |
| 2026-01-08 | 2026-01-12 | 173.47 |
| 2025-11-20 | 2025-12-15 | 0.73 |
| 2025-11-18 | 2025-11-19 | 376.52 |
| 2025-11-15 | 2025-11-17 | 373.22 |
| 2025-08-25 | 2025-11-14 | 0.73 |
| 2025-08-21 | 2025-08-24 | 1.66 |
| 2025-08-14 | 2025-08-20 | 0.73 |
| 2025-07-25 | 2025-08-13 | 0.86 |
| 2025-06-19 | 2025-07-24 | 0.73 |
| 2025-06-17 | 2025-06-17 | 359.1 |
| 2025-05-19 | 2025-06-12 | 0.73 |
| 2025-05-17 | 2025-05-18 | 0.19 |
| 2025-03-16 | 2025-03-16 | 352.14 |
| 2025-03-15 | 2025-03-15 | 350.88 |
| 2025-02-13 | 2025-02-17 | 0.89 |
| 2025-01-10 | 2025-01-14 | 349.76 |
| 2024-11-20 | 2024-11-23 | 1.16 |
| 2024-11-17 | 2024-11-19 | 535.94 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Farmacijos investicijos, UAB, a Private Limited Liability Company, is registered under code 300022793 and operates in freight transport by road. In the latest financial year, 2025, the company generated revenue of EUR 19.0K and recorded a net loss of EUR 5.0K, resulting in a negative profit margin of 26.3%. Revenue declined by 20.8% year on year from EUR 24.0K in 2024, although it remained 52.0% above the 2023 level of EUR 12.5K. Profitability was volatile over the three-year period: a loss of EUR 7.4K in 2023 was followed by a profit of EUR 1.8K in 2024 and then another loss in 2025. At the end of 2025, total assets stood at EUR 59.0K, supported by equity of EUR 56.4K and liabilities of EUR 2.6K. The equity ratio was 95.6%, while debt to equity remained low at 0.05. Asset turnover was 0.32x, and revenue per employee was EUR 6.3K. The balance sheet was dominated by short-term assets, while long-term assets were minimal at EUR 240.